AstraZeneca PLC (AZNCF)
OTCMKTS · Delayed Price · Currency is USD
187.10
+3.93 (2.15%)
At close: Jan 30, 2026
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of $289.37 billion as of January 30, 2026. Its market cap has increased by 37.06% in one year.
Market Cap
289.37B
Enterprise Value
314.44B
Revenue
58.13B
Ranking
n/a
PE Ratio
30.79
Stock Price
$187.10
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 7.10B to 289.37B, an increase of 3,975.09%. That is a compound annual growth rate of 12.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 289.37B | 0.54% |
| Dec 31, 2025 | 287.81B | 41.66% |
| Dec 31, 2024 | 203.17B | -2.91% |
| Dec 29, 2023 | 209.27B | -0.08% |
| Dec 30, 2022 | 209.44B | 15.06% |
| Dec 31, 2021 | 182.03B | 38.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 809.26M |
| Glass House Brands | 738.52M |
| Elite Pharmaceuticals | 472.22M |
| Northwest Biotherapeutics | 460.50M |
| Nika Pharmaceuticals | 403.38M |
| American Oncology Network | 394.41M |
| CytoDyn | 314.83M |
| Silence Therapeutics | 234.28M |